Engineered viruses are the delivery vehicle of choice for many genetic medicines, but they pose several problems. In addition to the risk of dangerous immune responses, these viruses don’t go to all ...
GREATER PHILADELPHIA, Pa.--(BUSINESS WIRE)--Code Biotherapeutics, Inc. (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and ...
PHILADELPHIA, Pa.--(BUSINESS WIRE)--Code Biotherapeutics, Inc. (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announces the appointment of David ...
Duchenne muscular dystrophy (DMD) and Type 1 diabetes couldn’t be more different: One is fairly rare and degenerative, while we hear about the other life-altering condition all the time. A new biotech ...
Code Biotherapeutics expects to double in size after raising $75M to advance gene therapy candidates
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company's first two targets are Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results